112 related articles for article (PubMed ID: 12777209)
1. Presence of atrial natriuretic factor in normal and hyperplastic human prostate and its relationship with oxytocin localisation.
Farina-Lipari E; Lipari D; Bellafiore M; Anzalone R; Cappello F; Valentino B
Eur J Histochem; 2003; 47(2):133-8. PubMed ID: 12777209
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
Giri D; Ittmann M
Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
[TBL] [Abstract][Full Text] [Related]
3. The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions.
Leav I; McNeal JE; Ziar J; Alroy J
Hum Pathol; 1998 Jul; 29(7):668-75. PubMed ID: 9670822
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin, oxytocin-associated neurophysin and the oxytocin receptor in the human prostate.
Whittington K; Assinder S; Gould M; Nicholson H
Cell Tissue Res; 2004 Nov; 318(2):375-82. PubMed ID: 15459766
[TBL] [Abstract][Full Text] [Related]
5. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
Li W; Wu CL; Febbo PG; Olumi AF
Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
[TBL] [Abstract][Full Text] [Related]
6. Monodispersal and deoxyribonucleic acid analysis of prostatic cell nuclei.
Goerttler K; Ehemann V; Tschahargane C; Stoehr M
J Histochem Cytochem; 1977 Jul; 25(7):560-4. PubMed ID: 70447
[TBL] [Abstract][Full Text] [Related]
7. Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway.
Xu H; Fu S; Chen Y; Chen Q; Gu M; Liu C; Qiao Z; Zhou J; Wang Z
Clin Sci (Lond); 2017 Apr; 131(7):595-607. PubMed ID: 28130436
[TBL] [Abstract][Full Text] [Related]
8. Atypical intraepithelial lesions of the prostate gland.
Murphy WM
Am J Clin Pathol; 1991 Nov; 96(5):561-3. PubMed ID: 1719794
[No Abstract] [Full Text] [Related]
9. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate.
Zhang Y; Nojima S; Nakayama H; Jin Y; Enza H
Oncol Rep; 2003; 10(1):207-11. PubMed ID: 12469170
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model.
Schauer IG; Ressler SJ; Rowley DR
Prostate; 2009 Mar; 69(4):373-84. PubMed ID: 19021203
[TBL] [Abstract][Full Text] [Related]
11. [Benign mimickers of prostatic adenocarcinoma: diagnostic features and differential diagnosis].
Cheng L; Huang W; Li Y; Wang L
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):52-8. PubMed ID: 24713255
[No Abstract] [Full Text] [Related]
12. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
[TBL] [Abstract][Full Text] [Related]
13. A Detailed Analysis of Gene Expression in Human Basal, Luminal, and Stromal Cell Populations from Benign Prostatic Hyperplasia Tissues and Comparisons with Cultured Basal Cells.
Rane JK; Droop AP; Maitland NJ
Eur Urol; 2017 Jul; 72(1):157-159. PubMed ID: 28385452
[No Abstract] [Full Text] [Related]
14. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate.
Whittington K; Connors B; King K; Assinder S; Hogarth K; Nicholson H
Prostate; 2007 Jul; 67(10):1132-42. PubMed ID: 17492653
[TBL] [Abstract][Full Text] [Related]
15. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
Giri D; Ropiquet F; Ittmann M
J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
17. [Echomorphology of the prostate].
Frentzel-Beyme B; Ledwa D
Ultraschall Med; 1986 Feb; 7(1):7-16. PubMed ID: 2421404
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical localisation of follicle stimulating hormone (FSH) in normal, benign and malignant human prostates.
Hurkadli KS; Sheth AR; Garde SV; Doctor VM; Sheth NA
Br J Cancer; 1990 Feb; 61(2):225-9. PubMed ID: 2106911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
